Intelligent Bio Solutions issues 75,000 restricted shares for advisory services By Investing.com Intelligent Bio Solutions issues 75,000 restricted shares for advisory services…
INBS Stock May Rise on SMARTOX Partnership Expanding Forensic Reach Intelligent Bio Solutions collaborates with SMARTOX to expand U.S. forensic reach, boosting its drug test tech and eyeing FDA clearance…
Intelligent Bio Solutions to Expand U.S. IP Portfolio with Expected Patent Grant NEW YORK, March 20, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”),…
Intelligent Bio Solutions Inc. Announces Proposed Public Offering of Common Stock NEW YORK, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (the “Company”) a medical…
INBS Stock Declines Despite Positive Results of Pharmacokinetic Study Intelligent Bio Solutions unveils strong initial results for its PK study, which is important for FDA submission of its Intelligent…
Intelligent Bio Solutions Inc. Reports Fiscal 2024 Fourth Quarter and Full Year Financial Results and Operational Highlights - Fourth-quarter revenue of $0.73 million, up 64% year-over-year –…
Intelligent Bio Solutions Inc. Reports Fiscal 2024 Third Quarter and Nine-Month Financial Results and Operational Highlights Year-over-year revenue increased 80% for the fiscal third quarter and 193% for the nine months ended March 31, 2024…
Intelligent Bio Solutions secures $10.1 million in private placement By Investing.com Intelligent Bio Solutions secures $10.1 million in private placement…